Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who have maintained a molecular response can successfully discontinue treatment without relapsing. Treatment free remission (TFR) can be reached b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Clin Oncol
Autori principali: Stuckey, Ruth, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, Segura-Díaz, Adrián, Sánchez-Farías, Nuria, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Inc 2020
Soggetti:
Minireviews
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769711/
https://ncbi.nlm.nih.gov/pubmed/33437662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i12.996
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi